In Situ Hybridization (ISH) is a process that utilizes labeled DNA or RNA probes to detect complementary DNA or RNA sites in a piece of tissue or in cytological preparation. This technique allows to gain temporary and three-dimensional information about gene expression and genetic site. The in-situ hybridization is similar to the blot hybridization.
The market for in situ hybridization (ISH) is expected to grow with a significant rate due to the factors such as, high prevalence of the cancer and infectious diseases, increase in the neuroscience studies, rise in the study and development of the neuroscience, immunology, microbiology and cytology. As the regulatory bodies are funding enormously for the healthcare industry, the players are receiving great opportunities to grow their market share in the biotechnological industry.
The “Global In Situ Hybridization (ISH) Market Analysis to 2025” is a specialized and in-depth study of the In Situ Hybridization (ISH) industry with a focus on the global market trend. The report aims to provide an overview of global in situ hybridization (ISH) market with detailed market segmentation by technology, application, end user and geography. The global in situ hybridization (ISH) market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The in situ hybridization (ISH) market is segmented based on technology as, chromogenic in situ hybridization (CISH) and fluorescence in situ hybridization (FISH). The application segment is classified as, immunology, microbiology, cancer diagnostic, neuroscience, and infectious diseases. The end user is segment is classified as biotechnology/ pharmaceutical companies, academic & research institutes, molecular diagnostic labs.
The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global In Situ Hybridization (ISH) market based on, technology, application and end user. It also provides market size and forecast till 2025 for overall in situ hybridization (ISH) market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
North America is anticipated as the largest market for in situ hybridization (ISH) market in the global scenario as the rise in the biological and clinical research for cancer diagnostic are been conducted by the various pharmaceutical and biotechnological companies. Filing for the patent right motivates the small companies to conduct more research for the various techniques that will give them more opportunities to expand their product portfolio and also to expand their geographic presence.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key In Situ Hybridization (ISH) manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Abbott, ThermoFisher Scientific, Inc., PerkinElmer Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, Danaher, BioGenex, Bio SB, Exiqon (QIAGEN), and Oxford Gene Technology.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.